Xiangji Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiangji Jin has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Tae-Hoo Yi
Graduate School of Biotechnology, Kyung Hee University, Yongin-si, Republic of Korea
18 shared publications - Trang Thi Minh Nguyen
Kyung Hee University
17 shared publications - Qiwen Zheng
Kyung Hee University
16 shared publications - Gyeong-Seon Yi
Department of Biopharmaceutical Biotechnology, Graduate School, Kyung Hee University, 1732 Deogyeong-daero, Giheung-gu, Yongin-si 17104, Republic of Korea
13 shared publications - Su-Jin Yang
Graduate School of Biotechnology, Kyung Hee University, 1732 Deogyeong-daero, Giheung-gu, Yongin-si 17104, Republic of Korea
12 shared publications - Se-Jig Park
Graduate School of Biotechnology, Kyung Hee University, 1732 Deogyeong-daero, Giheung-gu, Yongin-si 17104, Republic of Korea
10 shared publications
Latest Publications
- 18 November 2025
- Published by Springer Nature
- p. 275-303
Smart Nanomaterials in Tissue Engineering: Scaffolds, Bioprinting, and Stem Cell Integration
- 18 November 2025
- Published by Springer Nature
- p. 275-303
Smart Nanomaterials in Tissue Engineering: Scaffolds, Bioprinting, and Stem Cell Integration
- Open Access
Fatty Acid-Rich Fraction of Hibiscus syriacus L. Alleviates Atopic Dermatitis-like Skin Lesions Mouse Model via Inflammatory Pathway Modulation: Integrative Docking and Experimental Validation
Atopic dermatitis (AD) remains a therapeutic challenge due to the limitations of current treatments, creating demand for safer multi-target alternatives to corticosteroids. Our integrated study establishes Hibiscus syriacus L. (H. syriacus) as a mechanistically validated solution through computational and biological validation. The fraction’s two main compounds, linoleic acid and palmitic acid, exhibit favorable drug-like properties including high lipophilicity (LogP 5.2) and 87% oral absorption. Molecular docking collectively predicts comprehensive NF-κB pathway blockade. Experimental validation showed that the fraction (100 μg/mL) inhibited LPS-induced nitric oxide (NO) by 78% and TNF-α/IFN-γ-induced reactive oxygen species (ROS) by 40%, while significantly downregulating the chemokines TARC (73%) and MDC (71%). In DNCB-induced AD mice, the treatment (200 mg/kg/day) produced a 62% improvement in clinical severity scores, reduced serum IgE by 27%, decreased transepidermal water loss by 36%, and doubled skin hydration while normalizing pH levels from the alkaline to physiological range. While both treatments reduced DNCB-induced epidermal hyperplasia, H. syriacus (62.9% reduction) restored the normal thickness without pathological thinning, a critical advantage over corticosteroids that cause atrophy. This dual-action therapeutic achieves corticosteroid-level anti-inflammatory effects while restoring skin barrier integrity to normal levels and avoiding corticosteroid-associated atrophy, positioning it as a next-generation AD treatment.
Open AccessFatty Acid-Rich Fraction of Hibiscus syriacus L. Alleviates Atopic Dermatitis-like Skin Lesions Mouse Model via Inflammatory Pathway Modulation: Integrative Docking and Experimental Validation
Atopic dermatitis (AD) remains a therapeutic challenge due to the limitations of current treatments, creating demand for safer multi-target alternatives to corticosteroids. Our integrated study establishes Hibiscus syriacus L. (H. syriacus) as a mechanistically validated solution through computational and biological validation. The fraction’s two main compounds, linoleic acid and palmitic acid, exhibit favorable drug-like properties including high lipophilicity (LogP 5.2) and 87% oral absorption. Molecular docking collectively predicts comprehensive NF-κB pathway blockade. Experimental validation showed that the fraction (100 μg/mL) inhibited LPS-induced nitric oxide (NO) by 78% and TNF-α/IFN-γ-induced reactive oxygen species (ROS) by 40%, while significantly downregulating the chemokines TARC (73%) and MDC (71%). In DNCB-induced AD mice, the treatment (200 mg/kg/day) produced a 62% improvement in clinical severity scores, reduced serum IgE by 27%, decreased transepidermal water loss by 36%, and doubled skin hydration while normalizing pH levels from the alkaline to physiological range. While both treatments reduced DNCB-induced epidermal hyperplasia, H. syriacus (62.9% reduction) restored the normal thickness without pathological thinning, a critical advantage over corticosteroids that cause atrophy. This dual-action therapeutic achieves corticosteroid-level anti-inflammatory effects while restoring skin barrier integrity to normal levels and avoiding corticosteroid-associated atrophy, positioning it as a next-generation AD treatment.
- Open Access
Bauhinia forficata Link Protects HaCaT Keratinocytes from H2O2-Induced Oxidative Stress and Inflammation via Nrf2/PINK1 and NF-κB Signaling Pathways
Oxidative stress has been directly implicated in the pathogenesis of various skin disorders, making it a promising target for therapeutic intervention. Bauhinia forficata Link (BFL), commonly referred to as “plant insulin,” is well known for its antioxidant and antihyperglycemic properties; however, its potential role in skin protection remains unexplored. In this study, we investigated the protective effects of BFL against H2O2-induced oxidative stress and inflammation in HaCaT keratinocytes. The major phytochemical constituents of BFL were identified by high-performance liquid chromatography (HPLC). Its antioxidant capacity was evaluated using 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,2-Diphenyl-1-picrylhydrazyl (DPPH), oxygen radical absorbance capacity (ORAC), and superoxide dismutase (SOD). In an H2O2-induced oxidative stress model, we assessed intracellular reactive oxygen species (ROS) levels and apoptosis using flow cytometry. Cellular respiration was analyzed using a Seahorse XFp analyzer, while molecular mechanisms were examined by reverse transcription polymerase chain reaction (RT-PCR) and western blotting. Our results demonstrated that BFL significantly reduced intracellular ROS levels and apoptosis, primarily by activating the nuclear factor erythroid 2–related factor 2 (Nrf2)/PINK1 pathway, which promoted mitochondrial quality control and redox homeostasis. Additionally, BFL suppressed inflammatory responses by downregulating the nuclear factor-κB (NF-κB) signaling pathway and reducing the secretion of pro-inflammatory cytokines interleukin (IL)-6, IL-1β, and tumor necrosis factor-alpha (TNF-α). These findings suggest that BFL is a potent antioxidant and anti-inflammatory agent, with potential as an adjunctive therapy for oxidative stress-related skin conditions.
Open AccessBauhinia forficata Link Protects HaCaT Keratinocytes from H2O2-Induced Oxidative Stress and Inflammation via Nrf2/PINK1 and NF-κB Signaling Pathways
Oxidative stress has been directly implicated in the pathogenesis of various skin disorders, making it a promising target for therapeutic intervention. Bauhinia forficata Link (BFL), commonly referred to as “plant insulin,” is well known for its antioxidant and antihyperglycemic properties; however, its potential role in skin protection remains unexplored. In this study, we investigated the protective effects of BFL against H2O2-induced oxidative stress and inflammation in HaCaT keratinocytes. The major phytochemical constituents of BFL were identified by high-performance liquid chromatography (HPLC). Its antioxidant capacity was evaluated using 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,2-Diphenyl-1-picrylhydrazyl (DPPH), oxygen radical absorbance capacity (ORAC), and superoxide dismutase (SOD). In an H2O2-induced oxidative stress model, we assessed intracellular reactive oxygen species (ROS) levels and apoptosis using flow cytometry. Cellular respiration was analyzed using a Seahorse XFp analyzer, while molecular mechanisms were examined by reverse transcription polymerase chain reaction (RT-PCR) and western blotting. Our results demonstrated that BFL significantly reduced intracellular ROS levels and apoptosis, primarily by activating the nuclear factor erythroid 2–related factor 2 (Nrf2)/PINK1 pathway, which promoted mitochondrial quality control and redox homeostasis. Additionally, BFL suppressed inflammatory responses by downregulating the nuclear factor-κB (NF-κB) signaling pathway and reducing the secretion of pro-inflammatory cytokines interleukin (IL)-6, IL-1β, and tumor necrosis factor-alpha (TNF-α). These findings suggest that BFL is a potent antioxidant and anti-inflammatory agent, with potential as an adjunctive therapy for oxidative stress-related skin conditions.
- Open Access
- 8 May 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (5) , 1093
Assessment of Antimicrobial Activity and Safety of Pediococcus pentosaceus Isolated from Ginseng as a Functional Cosmetic Ingredient
Lactic acid bacteria (LAB) are gaining increasing attention as functional ingredients in the cosmetic industry, particularly those derived from natural plant sources. Although various LAB strains have been widely applied in cosmetic formulations, studies investigating the effects of naturally derived LAB on the skin remain limited. In this study, we isolated an LAB strain from ginseng and evaluated its potential as a functional cosmetic ingredient. The antimicrobial activity of the strain was assessed against skin-associated pathogens Staphylococcus aureus and Staphylococcus epidermidis, while cytotoxicity was evaluated using HaCaT and Caco-2 cells. Considering the limitations of vertebrate animal testing, infection and survival assays were conducted using Galleria mellonella larvae as an alternative in vivo model. The ginseng-derived strain exhibited 99.93% similarity to Pediococcus pentosaceus and was designated P. pentosaceus THG-219. It exhibited an MIC of 0.625 mg/mL and 1.25 mg/mL against S. aureus KCTC 3881 and S. epidermidis KCTC 1917, respectively. Its antimicrobial activity was further enhanced following ethyl acetate fractionation. P. pentosaceus THG-219 showed no toxicity in G. mellonella larvae and exerted antibacterial effects in this model. No cytotoxicity was observed in HaCaT and Caco-2 cells. Furthermore, P. pentosaceus THG-219 promoted host cell adhesion while inhibiting pathogen adhesion. It also exhibited excellent acid, bile, and heat tolerance, suggesting strong survivability under harsh conditions. Collectively, these results indicate that P. pentosaceus THG-219, isolated from ginseng, is a promising, safe, and stable candidate for development as a functional cosmetic ingredient.
- 8 May 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (5) , 1093
Open AccessAssessment of Antimicrobial Activity and Safety of Pediococcus pentosaceus Isolated from Ginseng as a Functional Cosmetic Ingredient
Lactic acid bacteria (LAB) are gaining increasing attention as functional ingredients in the cosmetic industry, particularly those derived from natural plant sources. Although various LAB strains have been widely applied in cosmetic formulations, studies investigating the effects of naturally derived LAB on the skin remain limited. In this study, we isolated an LAB strain from ginseng and evaluated its potential as a functional cosmetic ingredient. The antimicrobial activity of the strain was assessed against skin-associated pathogens Staphylococcus aureus and Staphylococcus epidermidis, while cytotoxicity was evaluated using HaCaT and Caco-2 cells. Considering the limitations of vertebrate animal testing, infection and survival assays were conducted using Galleria mellonella larvae as an alternative in vivo model. The ginseng-derived strain exhibited 99.93% similarity to Pediococcus pentosaceus and was designated P. pentosaceus THG-219. It exhibited an MIC of 0.625 mg/mL and 1.25 mg/mL against S. aureus KCTC 3881 and S. epidermidis KCTC 1917, respectively. Its antimicrobial activity was further enhanced following ethyl acetate fractionation. P. pentosaceus THG-219 showed no toxicity in G. mellonella larvae and exerted antibacterial effects in this model. No cytotoxicity was observed in HaCaT and Caco-2 cells. Furthermore, P. pentosaceus THG-219 promoted host cell adhesion while inhibiting pathogen adhesion. It also exhibited excellent acid, bile, and heat tolerance, suggesting strong survivability under harsh conditions. Collectively, these results indicate that P. pentosaceus THG-219, isolated from ginseng, is a promising, safe, and stable candidate for development as a functional cosmetic ingredient.
- 18 April 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 204, 107614
Potent oral health benefits and teeth bleaching effects of Latilactobacillus sakei THY-B1 isolated from broccoli
- 18 April 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 204, 107614
Potent oral health benefits and teeth bleaching effects of Latilactobacillus sakei THY-B1 isolated from broccoli
- Open Access
- 8 April 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (4) , 389
Antimicrobial Activity of Pediococcus pentosaceus PMY2 Against Multidrug-Resistant Pathogens
Background/Objectives: Multidrug-resistant (MDR) pathogens pose a critical challenge in infection treatment. Pediococcus pentosaceus (P. pentosaceus) is known for its antimicrobial activity; however, studies on its effects against MDR pathogens remain limited. This study aimed to evaluate the antimicrobial and biological activities of P. pentosaceus PMY2, isolated from fermented porcine colostrum yogurt, against MDR pathogens, including Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), and Escherichia coli (E. coli). Methods: The antimicrobial, anti-inflammatory, and cytotoxic effects of P. pentosaceus PMY2 were evaluated in vitro. In addition, IL-6 and TNF-α levels were analyzed using an ELISA kit. Results: The MIC value against S. aureus KCTC 3881 and MRSA (CCARM 3089) was 0.31 mg/mL, while the MBC values were 0.63 mg/mL and 2.5 mg/mL, respectively. At MIC, biofilm formation was inhibited by 62.2% in S. aureus KCTC 3881 and by 51.5% in MRSA. CFS exhibited low cytotoxicity in RAW 264.7 macrophages and significantly reduced NO production, IL-6, and TNF-α levels, indicating strong anti-inflammatory effects. Conclusions: These findings suggest that P. pentosaceus PMY2 exhibited excellent antimicrobial and anti-inflammatory activity against MDR pathogens, demonstrating its potential as a natural antimicrobial agent. These results indicate that PMY2 CFS could be a promising candidate for addressing antibiotic resistance issues.
- 8 April 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (4) , 389
Open AccessAntimicrobial Activity of Pediococcus pentosaceus PMY2 Against Multidrug-Resistant Pathogens
Background/Objectives: Multidrug-resistant (MDR) pathogens pose a critical challenge in infection treatment. Pediococcus pentosaceus (P. pentosaceus) is known for its antimicrobial activity; however, studies on its effects against MDR pathogens remain limited. This study aimed to evaluate the antimicrobial and biological activities of P. pentosaceus PMY2, isolated from fermented porcine colostrum yogurt, against MDR pathogens, including Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), and Escherichia coli (E. coli). Methods: The antimicrobial, anti-inflammatory, and cytotoxic effects of P. pentosaceus PMY2 were evaluated in vitro. In addition, IL-6 and TNF-α levels were analyzed using an ELISA kit. Results: The MIC value against S. aureus KCTC 3881 and MRSA (CCARM 3089) was 0.31 mg/mL, while the MBC values were 0.63 mg/mL and 2.5 mg/mL, respectively. At MIC, biofilm formation was inhibited by 62.2% in S. aureus KCTC 3881 and by 51.5% in MRSA. CFS exhibited low cytotoxicity in RAW 264.7 macrophages and significantly reduced NO production, IL-6, and TNF-α levels, indicating strong anti-inflammatory effects. Conclusions: These findings suggest that P. pentosaceus PMY2 exhibited excellent antimicrobial and anti-inflammatory activity against MDR pathogens, demonstrating its potential as a natural antimicrobial agent. These results indicate that PMY2 CFS could be a promising candidate for addressing antibiotic resistance issues.
- Open Access
A PRISMA Systematic Review of Sexual Dysfunction and Probiotics with Pathophysiological Mechanisms
Sexual dysfunction, influenced by hormonal imbalances, psychological factors, and chronic diseases, affects a significant portion of the population. Probiotics, known for their beneficial effects on gut microbiota, have emerged as potential therapeutic agents for improving sexual health. This systematic review evaluates the impact of probiotics on sexual function, hormonal regulation, and reproductive outcomes. A comprehensive search identified 3308 studies, with 12 meeting the inclusion criteria—comprising 10 randomized controlled trials (RCTs) and 2 in vivo and in vitro studies. Probiotic interventions were shown to significantly improve sexual function, particularly in women undergoing antidepressant therapy (p < 0.05). Significant improvements in Female Sexual Function Index (FSFI) scores were observed, with combined treatments such as Lactofem with Letrozole and Lactofem with selective serotonin reuptake inhibitors (SSRIs) demonstrating a 10% biochemical and clinical pregnancy rate compared to 0% in the control group (p = 0.05). Probiotic use was also associated with a 66% reduction in menopausal symptoms, increased sperm motility (36.08%), viability (46.79%), and morphology (36.47%). Probiotics also contributed to favorable hormonal changes, including a reduced luteinizing hormone (LH) to follicle-stimulating hormone (FSH) ratio (from 3.0 to 2.5, p < 0.05) and increased testosterone levels. Regarding reproductive outcomes, probiotic use was associated with higher pregnancy rates in women undergoing fertility treatments and improvements in sperm motility, viability, and morphology in men. This review highlights the promising role of probiotics in addressing sexual dysfunction and reproductive health, suggesting their potential as adjunctive treatments for conditions such as depression and infertility. Further research is needed to better understand the underlying mechanisms of these beneficial effects.
Open AccessA PRISMA Systematic Review of Sexual Dysfunction and Probiotics with Pathophysiological Mechanisms
Sexual dysfunction, influenced by hormonal imbalances, psychological factors, and chronic diseases, affects a significant portion of the population. Probiotics, known for their beneficial effects on gut microbiota, have emerged as potential therapeutic agents for improving sexual health. This systematic review evaluates the impact of probiotics on sexual function, hormonal regulation, and reproductive outcomes. A comprehensive search identified 3308 studies, with 12 meeting the inclusion criteria—comprising 10 randomized controlled trials (RCTs) and 2 in vivo and in vitro studies. Probiotic interventions were shown to significantly improve sexual function, particularly in women undergoing antidepressant therapy (p < 0.05). Significant improvements in Female Sexual Function Index (FSFI) scores were observed, with combined treatments such as Lactofem with Letrozole and Lactofem with selective serotonin reuptake inhibitors (SSRIs) demonstrating a 10% biochemical and clinical pregnancy rate compared to 0% in the control group (p = 0.05). Probiotic use was also associated with a 66% reduction in menopausal symptoms, increased sperm motility (36.08%), viability (46.79%), and morphology (36.47%). Probiotics also contributed to favorable hormonal changes, including a reduced luteinizing hormone (LH) to follicle-stimulating hormone (FSH) ratio (from 3.0 to 2.5, p < 0.05) and increased testosterone levels. Regarding reproductive outcomes, probiotic use was associated with higher pregnancy rates in women undergoing fertility treatments and improvements in sperm motility, viability, and morphology in men. This review highlights the promising role of probiotics in addressing sexual dysfunction and reproductive health, suggesting their potential as adjunctive treatments for conditions such as depression and infertility. Further research is needed to better understand the underlying mechanisms of these beneficial effects.
- Open Access
Lithospermum erythrorhizon and Forsythia suspensa Prevent Collagen Degradation and Maintain Skin Hydration by Regulating MMPs and HAS2/HYAL1 Signaling
The growing demand for aesthetic enhancement has driven the development of anti-aging cosmetics, with natural compound-based formulations emerging as a new trend to enhance efficacy. This study aims to develop a 30% ethanol extract of a 1:1 mixture of Lithospermum erythrorhizon and Forsythia suspensa (LF) as a potential material for combating UVB-induced skin aging. The bioactive components of LF extract were identified via HPLC. Antioxidant efficacy (DPPH, ABTS, and SOD) and the inhibitory effects on ROS production in cells were evaluated using flow cytometry. MMPs’ expressions were analyzed via RT-PCR, while TGF-β/Smad, ERK/AP-1, and HAS2/HYAL1 pathways were examined via ELISA and Western blot. Research findings indicate that LF effectively scavenges reactive oxygen species and enhances the activation of TGF-β signaling, promoting the synthesis of PIP (Procollagen Type I C-Peptide). Collagen degradation was mitigated through the inhibition of the AP-1 pathway, which regulates the expression of MMPs, and by suppressing the expression of TIMP. Additionally, modulation of the HAS2/HYAL1 signaling axis ensures a balanced regulation of hyaluronic acid (HA) synthesis and degradation, thereby contributing to the maintenance of collagen integrity and skin hydration. In conclusion, LF has exhibited significant protective effects against demonstrated anti-aging properties, highlighting its potential as a novel therapeutic agent in cosmetic formulations targeting aging.
Open AccessLithospermum erythrorhizon and Forsythia suspensa Prevent Collagen Degradation and Maintain Skin Hydration by Regulating MMPs and HAS2/HYAL1 Signaling
The growing demand for aesthetic enhancement has driven the development of anti-aging cosmetics, with natural compound-based formulations emerging as a new trend to enhance efficacy. This study aims to develop a 30% ethanol extract of a 1:1 mixture of Lithospermum erythrorhizon and Forsythia suspensa (LF) as a potential material for combating UVB-induced skin aging. The bioactive components of LF extract were identified via HPLC. Antioxidant efficacy (DPPH, ABTS, and SOD) and the inhibitory effects on ROS production in cells were evaluated using flow cytometry. MMPs’ expressions were analyzed via RT-PCR, while TGF-β/Smad, ERK/AP-1, and HAS2/HYAL1 pathways were examined via ELISA and Western blot. Research findings indicate that LF effectively scavenges reactive oxygen species and enhances the activation of TGF-β signaling, promoting the synthesis of PIP (Procollagen Type I C-Peptide). Collagen degradation was mitigated through the inhibition of the AP-1 pathway, which regulates the expression of MMPs, and by suppressing the expression of TIMP. Additionally, modulation of the HAS2/HYAL1 signaling axis ensures a balanced regulation of hyaluronic acid (HA) synthesis and degradation, thereby contributing to the maintenance of collagen integrity and skin hydration. In conclusion, LF has exhibited significant protective effects against demonstrated anti-aging properties, highlighting its potential as a novel therapeutic agent in cosmetic formulations targeting aging.
- 18 February 2025
- Published by Taylor & Francis in International Journal of Environmental Health Research
- Vol. 35 (10) , 2992-3005
Exploration of old-age odor inhibition and reduction by Leuconostoc mesenteroides THF-10 isolated from oriental melon
Old age odor is associated with delayed skin renewal and fatty acid oxidation by skin bacteria, potentially causing discomfort and health issues. While previous studies primarily targeted 2-nonenal inhibition, this study examined the antibacterial, antioxidant, biofilm inhibition, SDS-PAGE analysis, and trans-2-nonenal scavenging effects of Leuconostoc mesenteroides THF-10, a lactic acid bacterium isolated from Cucumis melo. The cell-free supernatant inhibited S. epidermidis, S. aureus, and P. aeruginosa, with MIC values of 1.25 mg/mL, which decreased to 0.31, 0.62, and 0.04 mg/mL after ethyl acetate fractionation. THF-10 effectively inhibited biofilm formation and exhibited enhanced antioxidant activity, leading to radical scavenging and a 39% reduction in ROS production at 20 µg/mL. The trans-2-nonenal scavenging assay demonstrated a 73% inhibition rate, with no observed toxicity in HaCaT cells. These findings suggest that L. mesenteroides THF-10 possesses strong antimicrobial and antioxidant properties, supporting its potential for mitigating old age odor.
- 18 February 2025
- Published by Taylor & Francis in International Journal of Environmental Health Research
- Vol. 35 (10) , 2992-3005
Exploration of old-age odor inhibition and reduction by Leuconostoc mesenteroides THF-10 isolated from oriental melon
Old age odor is associated with delayed skin renewal and fatty acid oxidation by skin bacteria, potentially causing discomfort and health issues. While previous studies primarily targeted 2-nonenal inhibition, this study examined the antibacterial, antioxidant, biofilm inhibition, SDS-PAGE analysis, and trans-2-nonenal scavenging effects of Leuconostoc mesenteroides THF-10, a lactic acid bacterium isolated from Cucumis melo. The cell-free supernatant inhibited S. epidermidis, S. aureus, and P. aeruginosa, with MIC values of 1.25 mg/mL, which decreased to 0.31, 0.62, and 0.04 mg/mL after ethyl acetate fractionation. THF-10 effectively inhibited biofilm formation and exhibited enhanced antioxidant activity, leading to radical scavenging and a 39% reduction in ROS production at 20 µg/mL. The trans-2-nonenal scavenging assay demonstrated a 73% inhibition rate, with no observed toxicity in HaCaT cells. These findings suggest that L. mesenteroides THF-10 possesses strong antimicrobial and antioxidant properties, supporting its potential for mitigating old age odor.
- Open Access
- 6 February 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (3) , 1647
Lactic Acid Bacteria from Kiwi: Antifungal and Biofilm-Inhibitory Activities Against Candida albicans
Urogenital infections impact millions of individuals globally each year, with vulvovaginal candidiasis (VVC) being one of the most prevalent conditions affecting women. Candida albicans is the primary pathogen responsible for VVC. The utilization of probiotics as an alternative therapeutic approach to antibiotics in managing such infections has gained increasing attention. This study aimed to evaluate the potential of THY-F51, a lactic acid bacterium isolated from kiwi, as a probiotic to support vaginal health through its antifungal, anti-biofilm, and anti-inflammatory properties against C. albicans. The identification of THY-F51 was confirmed through 16S rRNA gene sequencing. A series of evaluations were performed to determine its antifungal efficacy against C. albicans, biofilm-inhibitory activity, antioxidant properties, and effects on inflammatory cytokines. Cytotoxicity assays and assessments of bacterial survival under vaginal pH conditions (pH 3.8–4.5) were also conducted. The results demonstrated that THY-F51, identified as Leuconostoc citreum, exhibited potent antifungal activity against C. albicans, with an MIC of 1.25 mg/mL and an MFC of 2.5 mg/mL. Furthermore, THY-F51 displayed a strong inhibition of C. albicans biofilm formation, as well as notable antioxidant activity in the supernatant. Additionally, THY-F51 demonstrated high survival rates under vaginal pH conditions, an absence of cytotoxic effects, and a significant reduction in C. albicans adhesion to HeLa cells. Moreover, THY-F51 effectively suppressed C. albicans-induced inflammatory cytokines, including TNF-α, IL-1β, IL-6, and IL-8. These findings suggest that THY-F51, isolated from kiwi, holds substantial promise as a safe and effective probiotic for reducing vaginal inflammation and promoting vaginal health.
- 6 February 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (3) , 1647
Open AccessLactic Acid Bacteria from Kiwi: Antifungal and Biofilm-Inhibitory Activities Against Candida albicans
Urogenital infections impact millions of individuals globally each year, with vulvovaginal candidiasis (VVC) being one of the most prevalent conditions affecting women. Candida albicans is the primary pathogen responsible for VVC. The utilization of probiotics as an alternative therapeutic approach to antibiotics in managing such infections has gained increasing attention. This study aimed to evaluate the potential of THY-F51, a lactic acid bacterium isolated from kiwi, as a probiotic to support vaginal health through its antifungal, anti-biofilm, and anti-inflammatory properties against C. albicans. The identification of THY-F51 was confirmed through 16S rRNA gene sequencing. A series of evaluations were performed to determine its antifungal efficacy against C. albicans, biofilm-inhibitory activity, antioxidant properties, and effects on inflammatory cytokines. Cytotoxicity assays and assessments of bacterial survival under vaginal pH conditions (pH 3.8–4.5) were also conducted. The results demonstrated that THY-F51, identified as Leuconostoc citreum, exhibited potent antifungal activity against C. albicans, with an MIC of 1.25 mg/mL and an MFC of 2.5 mg/mL. Furthermore, THY-F51 displayed a strong inhibition of C. albicans biofilm formation, as well as notable antioxidant activity in the supernatant. Additionally, THY-F51 demonstrated high survival rates under vaginal pH conditions, an absence of cytotoxic effects, and a significant reduction in C. albicans adhesion to HeLa cells. Moreover, THY-F51 effectively suppressed C. albicans-induced inflammatory cytokines, including TNF-α, IL-1β, IL-6, and IL-8. These findings suggest that THY-F51, isolated from kiwi, holds substantial promise as a safe and effective probiotic for reducing vaginal inflammation and promoting vaginal health.